Thank you for signing up! Did you know with an ad-lite subscription to Northampton Chronicle and Echo, you get 70% fewer ads ...

Goldman Sachs 9th Annual Biopharma Innovation Summit March 26, 2026 5:00 AM EDTCompany ParticipantsKaivan Khavandi - Senior VP, Global Head ...

University leaders and panelists reflected on the impact of Notre Dame’s “What Would You Fight For?” campaign, highlighting ...

The University of Notre Dame will celebrate 20 years of its "What Would You Fight For?" series with panel discussion at 4 p.m ...

Cork University Hospital is the only public hospital offering the treatment under a pilot programme, Dáil committee heard ...

Younger siblings of peanut-consuming children have an increased risk for peanut sensitization and allergy, which can be mitigated by early introduction of peanuts, according to a study presented at ...

AIM-listed biotech reports biomarker results suggesting its VLP Peanut treatment could work in as few as three injections Allergy Therapeutics PLC (AIM:AGY, OTC:AGYTF, FRA:HHU), the AIM-listed allergy ...

PHILADELPHIA -- Peanut allergy immunotherapy delivered by an investigational skin patch increased the proportion of children ages 4 to 7 years who could tolerate a dose of peanut protein in the phase ...

The MarketWatch News Department was not involved in the creation of this content. Funding supports Mind Meld, FARE's research initiative designed to accelerate a cure for food allergy McLEAN, Va., Feb ...

Please provide your email address to receive an email when new articles are posted on . More children treated with the Viaskin Peanut patch vs. placebo were classified as responders at 12 months. DBV ...

Allergies are becoming more prevalent in the US, affecting over 100 million individuals. Common allergies include eczema, seasonal, and food allergies. Not surprisingly, food allergies can be the most ...